Health Care Services

By 11:48 am, the Dow Jones Industrial Average was up 93.20 points, or 0.78%, to 12,027.78, while the broader Standard & Poor's 500 index had surged 9.14 points, or 0.72%. The NASDAQ composite index rose 28.10 points, or 1.06%. Some of the narrow based indexes that are driving the markets are...

Icagen Inc (NASDAQ: ICGN) shares surged 129.18% to $5.50 at 9:45 am. Pfizer Inc (NYSE: PFE) reported that it is considering a strategic transaction with Icagen. Tiens Biotech Group (USA) Inc (AMEX: TBV) shares gained 64.08% to $1.69. TBV shares have dropped 43.72% over the past 52 weeks, while the...

First Global is out with its report today on Walgreens (NYSE: WAG), reiterating Market Perform. In a note to clients, First Global writes, "WAG has decided not to renew its contract with pharmacy benefit manager, Express Scripts Inc. (NASDAQ: ESRX), with effect from January 1, 2012, due to...

Shares of Continucare Corp (NYSE: CNU) jumped more than 17% in pre-market trading after Metropolitan Health Networks Inc (AMEX: MDF) announced its plans to buy Continucare for around $416 million in cash and stock. Under the deal, CNU's stakeholders would receive $6.25 in cash for each share of...

Pre-open movers US stock futures are higher this morning, as investors are awaiting data on consumer spending. Futures on the Dow Jones Industrial Average surged 26 points to 11,907.00 and futures on the S&P 500 stock index rose 4.20 points to 1,267.20. Nasdaq 100 futures jumped 7.75 points to...

Metropolitan Health Networks (NYSE: MDF) and Continucare Corporation (NYSE: CNU) announced jointly today that they have entered into a definitive merger agreement whereby Metropolitan will acquire Continucare in a cash and stock transaction valued at approximately $416 million at the time of...

DaVita Inc. (NYSE: DVA) shares just started to spike, trading at $85.83, up $1.44‎ after having traded lower during the session. DaVita Inc. provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States.

Bank of America reiterated its Buy rating on Express Scripts (NASDAQ: ESRX). At the same time, Bank of America decided to leave its price target on the company's stock unchanged at $67. On Thursday, Express Scripts closed the day at $54.06.

Deutsche Bank made a number of updates in a research report published today. NASDAQ OMX (NASDAQ: NDAQ) had its rating reiterated at Hold. At the same time, however, its price target was lowered from $30 to $27. On Thursday, NASDAQ lost 2.59% of its value to close the day at $23.35. CBOE Holdings...

Jefferies is out with its report today on Express Scripts (NASDAQ: ESRX), reiterating Buy. In a note to clients, Jefferies writes, "WAG (NYSE: WAG)/ESRX contract negotiations may be stalled for the moment but are far from dead. Potential earnings loss at WAG from a terminated ESRX relationship...

According to Citi, Medco Health Solutions (NYSE: MHS) Buy rating is maintained. Citi said that it recently attended the Drug Information Association (DIA) annual conference in Chicago and visited with the United BioSource (UBC) segment of Medco. “We maintain our Buy rating on MHS shares given the...

Susequehanna has upgraded Cross Country Healthcare (NASDAQ: CCRN) from Negative to Neutral and has raised the price target from $6 to $7.

Below are the top mid-cap insurance brokers stocks on the NYSE and the NASDAQ in terms of PEG ratio Catalyst Health Solutions Inc (NASDAQ: CHSI) has a PEG ratio of 1.26. CHSI's trailing-twelve-month revenue is $4.05 billion. Willis Group Holdings (NYSE: WSH) has a PEG ratio of 1.28. WSH's...

The S&P 500 traded in positive territory for most of session on Wednesday, but sellers came in around 2:25pm, as the index neared its intraday high of 1298.61. The S&P proceeded to drop 11.47 points to close at 1287.14 – down 8.38 on the day. The Sector Breakdown for Wednesday's session...

J.P. Morgan is out with its report on Express Scripts (NASDAQ: ESRX), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on Express Scripts is Overweight. We continue to point to the positive fundamental outlook for the PBM industry, based on the opportunity around...